R. Parasrampuria

Front-Loaded Linezolid Regimens Result in Increased Killing and Suppression of the Accessory Gene Regulator System of Staphylococcus aureus

Brian T. Tsuji, D. Brazeau, D. Hanna, 2012, Antimicrobial Agents and Chemotherapy.

Dose-dependent inhibition of transporter-mediated hepatic uptake and biliary excretion of methotrexate by cyclosporine A in an isolated perfused rat liver model.

R. Mehvar, R. Parasrampuria, 2010, Journal of pharmaceutical sciences.

A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants

Caifeng Fu, W. Spreen, A. Tenorio, 2019, Clinical pharmacology in drug development.

Effects of in vivo hepatic ischemia-reperfusion injury on the hepatobiliary disposition of rhodamine 123 and its metabolites in isolated perfused rat livers.

Reza Mehvar, R. Mehvar, Imam H Shaik, 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Development of Dolutegravir Single-entity and Fixed-dose Combination Formulations for Children

Allen Wolstenholme, K. Adkison, R. Parasrampuria, 2021, The Pediatric infectious disease journal.

Effects of P-glycoprotein and Mrp2 inhibitors on the hepatobiliary disposition of Rhodamine 123 and its glucuronidated metabolite in isolated perfused rat livers.

R. Mehvar, R. Parasrampuria, 2010, Journal of pharmaceutical sciences.

Stereospecific high-performance liquid chromatographic analysis of tramadol and its O-demethylated (M1) and N,O-demethylated (M5) metabolites in human plasma.

R. Mehvar, O. Eradiri, R. Parasrampuria, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Route-dependent stereoselective pharmacokinetics of tramadol and its active O-demethylated metabolite in rats.

R. Mehvar, R. Vuppugalla, R. Parasrampuria, 2007, Chirality.

METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

M. Gounder, D. Rasco, L. Siu, 2019, Annals of Oncology.